French pharmaceutical giant Sanofi said Tuesday that it would invest 2 billion euros ($2.4 billion) in the mRNA vaccine technology behind the pioneering Covid-19 jabs developed by rivals BioNTech-Pfizer and Moderna.
Jun 29, 2021
0
1
French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated COVID vaccine as they race to add their jab to the world's arsenal against the pandemic.
May 27, 2021
0
2
French pharmaceuticals giant Sanofi on Monday reported positive results in trials of its belated Covid-19 jab, raising hopes that France can finally make up lost ground after falling behind in the race to develop a vaccine.
May 17, 2021
0
1
French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second COVID-19 vaccine, with its first still in the testing phase after having fallen behind in development.
Mar 12, 2021
0
2
Fierce rivals normally, the COVID-19 crisis has led pharmaceutical companies to join forces to work together to produce the billions of vaccines needed globally.
Mar 3, 2021
0
1
In an unusual and potentially groundbreaking decision, French drugmaker Sanofi said Wednesday it will help bottle and package 125 million doses of the coronavirus vaccine developed by its rivals Pfizer and BioNTech, while ...
Jan 27, 2021
0
3
Sanofi, France's biggest pharmaceutical company, could help produce foreign-developed COVID-19 vaccines pending the launch of its own vaccine, which will not be ready for months, a government minister said Friday.
Jan 15, 2021
0
3
French pharmaceutical firm Sanofi and Britain's GSK have promised up to 72 million doses of their COVID-19 vaccine candidate to the Canadian government, which has already signed similar agreements with several American companies.
Sep 22, 2020
0
2
French pharmaceutical giant Sanofi on Thursday said it would start human trials of the potential coronavirus vaccine it is developing with British peer GSK, following promising preliminary tests.
Sep 3, 2020
0
4
French pharma giant Sanofi said Tuesday that international Phase 3 clinical tests of its Kevzara drug for serious COVID-19 cases had proved inconclusive and it was halting the trial.
Sep 1, 2020
0
12
